Compounds > nimustine

Page last updated: 2024-08-23

nimustine and Recrudescence

nimustine has been researched along with Recrudescence in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (66.67)	18.2507
2000's	2 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bratengeier, K; Flentje, M; Kölbl, O; Ruprecht, K; Vince, GH; Vordermark, D	1
Fujioka, K; Funabiki, T; Goto, H; Goto, S; Hanzawa, N; Ikuta, K; Izaki, S; Kai, S; Matsuda, M; Okuda, K; Sasaki, H; Sekiguchi, H; Sumita, H; Takahashi, H; Watanabe, Y; Yokota, S	1
Hyodo, A; Nose, T; Takada, K; Tsuboi, K; Yoshii, Y	1
Busch, R; Dengler, R; Eger, G; Emmerich, B; Münstermann, U; Plewan, A	1
Oguro, M; Sakai, C; Takagi, T	1
Kaneko, T; Matsuzawa, A; Takeda, Y	1

Trials

1 trial(s) available for nimustine and Recrudescence

Article	Year
Leukoencephalopathy associated with intra-arterial ACNU in patients with gliomas. Journal of neuro-oncology, 1995, Volume: 23, Issue:3 Topics: Adolescent; Adult; Aged; Brain; Brain Diseases; Brain Neoplasms; Combined Modality Therapy; Female; Glioma; Humans; Infant; Infusions, Intra-Arterial; Male; Middle Aged; Nimustine; Recurrence; Tomography, X-Ray Computed	1995

Other Studies

5 other study(ies) available for nimustine and Recrudescence

Article	Year
Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma. BMC cancer, 2005, May-30, Volume: 5 Topics: Antineoplastic Agents; Brain Neoplasms; Disease Progression; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Glioblastoma; Glioma; Humans; Neoplasm Recurrence, Local; Nimustine; Prognosis; Radiosurgery; Radiotherapy; Recurrence; Stereotaxic Techniques; Teniposide; Time Factors; Treatment Outcome	2005
Long-term follow-up of busulfan, etoposide, and nimustine hydrochloride (ACNU) or melphalan as conditioning regimens for childhood acute leukemia and lymphoma. International journal of hematology, 2007, Volume: 86, Issue:3 Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; Child, Preschool; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Infant; Leukemia; Lymphoma; Lymphoma, Non-Hodgkin; Male; Melphalan; Nimustine; Recurrence; Retrospective Studies; Stem Cell Transplantation; Survival Rate; Transplantation Conditioning; Transplantation, Homologous	2007
Urinary excretion of proteolyzed alpha1-antitrypsin: specificity, quantitation, and relation to therapy response in patients with acute myeloid leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research, 1995, Volume: 1, Issue:2 Topics: Adult; Aged; alpha 1-Antitrypsin; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Blast Crisis; Bleomycin; Bone Marrow; Cyclophosphamide; Dacarbazine; Danazol; Disease-Free Survival; Doxorubicin; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Nimustine; Peptide Fragments; Prednisone; Probability; Procarbazine; Prognosis; Proteinuria; Recurrence; Remission Induction; Reproducibility of Results; Tamoxifen; Time Factors; Vincristine	1995
[BH-AC.nitrosourea-therapy for refractory or relapsed malignant lymphoma]. Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nimustine; Nitrosourea Compounds; Recurrence	1992
Spergualin treatment-dependent delayed relapse of mouse T cell leukemia (DL812) after chemotherapy. The Japanese journal of antibiotics, 1991, Volume: 44, Issue:12 Topics: Animals; Guanidines; Leukemia, T-Cell; Male; Mice; Mice, Inbred Strains; Nimustine; Recurrence; Spleen	1991